首页> 外文会议>International Symposium on Hormonal Carcinogenesis >Premalignant Breast Disease: Anatomic Lesions and Hormonal Associations
【24h】

Premalignant Breast Disease: Anatomic Lesions and Hormonal Associations

机译:前乳腺疾病:解剖病变和荷尔蒙协助

获取原文

摘要

Breast cancer (BC) risk associations are many, and specific patterns of hyperplastic lesions, as revealed in biopsy tissue, are among the most widely accepted. A review of these lesions is presented in this chapter, along with their magnitude of BC risk and regional implications in women. In this chapter, the term ''premalignant' is used broadly, and indicate by the term 'disease' that the risk implications are of a magnitude that may have possible practical importance for an individual woman. Many of the risk associations that are well-known are just above 1.0. An age-corrected relative risk (RR) of 50% elevation in a period of 10-15 years after biopsy, has been adopted as a reference point to make suggested quantitative references (1) (ie., slight = 1.5-2.0 x; moderate - 4.0-5.0 x). Particularly important, and not recognized in the initial, formal epidemiologic studies of hyperplastic lesions in the breast, is the varied implication for site(s) and type of later BC presentation.
机译:乳腺癌(BC)风险关联是许多,在活组织检查组织中揭示的增生病变的特定模式是最广泛接受的。本章介绍了对这些病变的审查,以及他们对妇女的公元前风险的程度和区域影响。在本章中,术语“预展示剂”是广义使用的,并通过“疾病”一词的风险影响表明,风险影响是一个对个别女性可能的实际重要性的程度。许多众所周知的风险协会仅高于1.0。在活组织检查后10-15岁的时间内矫正了50%升高的年龄矫正风险(RR)作为参考点,以提出建议的定量参考(1)(即,轻微= 1.5-2.0 x;中等 - 4.0-5.0 x)。特别重要的,并且在乳房中的超增性病变的初始正式流行病学研究中特别重要,是对现场的变化和后期BC呈现类型的含义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号